| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |